These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4714196)

  • 1. [Clinico-bioelectric correlations in multiple myeloma with reference to effects of blood transfusion].
    Miszczak J; Uleniecki M
    Neurol Neurochir Pol; 1973; 7(3):399-402. PubMed ID: 4714196
    [No Abstract]   [Full Text] [Related]  

  • 2. [The use of autotransfusions of photo-modified blood in the combined treatment of hematology patients].
    Abdulkadyrov KM; Bessmel'tsev SS; Bel'chenko NA; Balashova VA
    Ter Arkh; 1992; 64(12):51-5. PubMed ID: 1292134
    [No Abstract]   [Full Text] [Related]  

  • 3. Myelomatosis in aplastic anaemia--a true association or fortuitous occurrence?
    Manoharan A; Horsley R; Pitney WR
    Pathology; 1981 Oct; 13(4):771-3. PubMed ID: 7335384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood and neoplastic diseases. Thrombocytopenia.
    Barkhan P
    Br Med J; 1974 May; 2(5914):324-5. PubMed ID: 4857083
    [No Abstract]   [Full Text] [Related]  

  • 5. [Transfusion of granulocytes. Methodological aspects and personal experience in forty cases (author's transl)].
    Ribas-Mundo M; Grañena A; Vivancos Pujol P; Castillo C; Rozman C
    Sangre (Barc); 1974; 19(1):73-88. PubMed ID: 4525208
    [No Abstract]   [Full Text] [Related]  

  • 6. Anemia in multiple myeloma.
    Ludwig H; Pohl G; Osterborg A
    Clin Adv Hematol Oncol; 2004 Apr; 2(4):233-41. PubMed ID: 16163188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evolution of acquired aplastic anemia to myelodysplasia and posterior multiple myeloma].
    Herraez García J; Campano Val F; Brull Sabate JM; Quiles Julián F
    An Med Interna; 1991 Jun; 8(6):313. PubMed ID: 1888852
    [No Abstract]   [Full Text] [Related]  

  • 8. Supportive therapy in multiple myeloma.
    Ludwig H; Zojer N
    Recent Results Cancer Res; 2011; 183():307-33. PubMed ID: 21509692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased blood viscosity and red blood cell aggregation in a patient with sickle cell anemia and smoldering myeloma.
    Lemonne N; Connes P; Romana M; Vent-Schmidt J; Bourhis V; Lamarre Y; Etienne-Julan M
    Am J Hematol; 2012 Nov; 87(11):E129. PubMed ID: 22930533
    [No Abstract]   [Full Text] [Related]  

  • 10. ABO discrepancy in a multiple myeloma patient: a case study.
    Wilson JA; Jacobs A
    Clin Lab Sci; 2002; 15(4):204-7. PubMed ID: 12776779
    [No Abstract]   [Full Text] [Related]  

  • 11. Hyperviscosity in myelomatosis--danger of over-transfusion [proceedings].
    Harrison EJ; Todd AS; Goodall HB
    Biorheology; 1978; 15(1):60-1. PubMed ID: 678635
    [No Abstract]   [Full Text] [Related]  

  • 12. V. Smoldering multiple myeloma.
    Mateos MV; San Miguel J
    Hematol Oncol; 2015 Jun; 33 Suppl 1():33-7. PubMed ID: 26062051
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of diffractometry of blood smears in the diagnosis of rheological disorders and assessment of the course of blood system diseases].
    Tarlykov VA; Bessmel'tsev SS; Andreeva NE; Gubarenko NK
    Klin Lab Diagn; 1997 Apr; (4):8-11. PubMed ID: 9221087
    [No Abstract]   [Full Text] [Related]  

  • 14. [Association of myeloma and hyperlipidemia with xanthomatous eruption].
    Cloarec M; Etienne J; Debray J
    Sem Hop; 1972 Dec; 48(52):3459-66. PubMed ID: 4349516
    [No Abstract]   [Full Text] [Related]  

  • 15. Nonsecretory myeloma in a child.
    Gogia A; Mishra J; Kumar R; Bakhshi S
    Pediatr Blood Cancer; 2011 Feb; 56(2):321-2. PubMed ID: 21157898
    [No Abstract]   [Full Text] [Related]  

  • 16. A case of phagocytic multiple myeloma.
    Invernizzi R; Pecci A
    Haematologica; 2000 Mar; 85(3):318. PubMed ID: 10702823
    [No Abstract]   [Full Text] [Related]  

  • 17. Neurological picture. Breach rhythm related to a solitary skull lesion caused by multiple myeloma.
    van Doorn J; Cherian PJ
    J Neurol Neurosurg Psychiatry; 2008 Jul; 79(7):819. PubMed ID: 18559461
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and toxicity of low-dose escalating donor lymphocyte infusion given after reduced intensity conditioning allograft for multiple myeloma.
    Ayuk F; Shimoni A; Nagler A; Schwerdtfeger R; Kiehl M; Sayer HG; Zabelina T; Zander AR; Kröger N
    Leukemia; 2004 Mar; 18(3):659-62. PubMed ID: 14671630
    [No Abstract]   [Full Text] [Related]  

  • 19. Multiple myeloma: prognostic factors and treatment modalities.
    Michiels JJ
    Neth J Med; 1992 Jun; 40(5-6):254-70. PubMed ID: 1436263
    [No Abstract]   [Full Text] [Related]  

  • 20. [Multiple myeloma and the kidneys].
    Kamaeva OI
    Ter Arkh; 1997; 69(6):73-5. PubMed ID: 9297284
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.